Unyango lwePancreatic Cancer 2026: Unyango olutsha lweCAR-T & ADC - Iindleko, izibhedlele 

Inguquko: Kutheni i-2026 ichaza kwakhona unyango loMhlaza wePancreatic

Umhlaza wePancreatic uhlala ungomnye wemiceli mngeni eyoyikekayo ye-oncology, kodwa umhlaba uguquka kakhulu ngo-2026. Kwiminyaka emininzi, izigulane zijongene neendlela ezilinganiselweyo kunye namazinga okuphila abuhlungu, kodwa i-CAR-T entsha ye-cell zonyango kunye ne-Antibody-Drug Conjugates (ADCs) ngoku inika ithemba elibonakalayo apho i-chemotherapy yakha yasilela. Sibona iikliniki zitshintsha kwihlabathi jikelele ukusuka kwiimodeli zokhathalelo lokuthomalalisa ukuya kwiiprothokholi ezinenjongo yonyango kwiintlobo ezithile zofuzo. Le indaleko kufuna ukuba izigulane kunye neentsapho ukuqonda nje inzululwazi, kodwa Logistics of unyango umhlaza pancreatic ezibandakanya ezi ndlela ziphambili. Ukufikelela kwinqanaba eliphezulu unyango umhlaza pancreatic ifuna ukukhangela imihlaba ye-inshorensi entsonkothileyo, ukuchonga amaziko awodwa, kunye nokulungiselela iiprofayili zeziphumo ezisecaleni ezizodwa ezahlukileyo kwiirejimeni zemveli.

Iqela lethu lilandelele idatha yolingo lwezonyango ukusuka kwii-hubs eziphambili eBoston, eHouston, naseLondon ngasekupheleni kuka-2025, iveza utyando kwi-FDA kunye nolwamkelo lweEMA kulwakhiwo lwesizukulwana esilandelayo. Ezi ayizozithembiso zethiyori; ziprothokholi ezisebenzayo ezikhoyo namhlanje. Izibhedlele ngoku zinika ingxelo yamazinga okuphendula kwiinjongo ezingaphaya kwama-40% kwiimeko ebezifudula zingavumi, inani elingazange libonwe kwiminyaka emihlanu eyadlulayo. Nangona kunjalo, ukusebenza okuphezulu kuzisa ubunzima obuphezulu. Ulwakhiwo lweendleko lwahluka kakhulu kunyango olusekwe kwi-gemcitabine olusemgangathweni, oluhlala lufuna inkunzi yangaphambili okanye izicelo zegranti ezikhethekileyo. Iintsapho kufuneka zivavanye iziqinisekiso zesibhedlele ngaphaya kodumo oluqhelekileyo, lujolise ngokukodwa kubuchule bokuvelisa unyango lweselula kunye neeyunithi zokulawula ubutyhefu be-ADC.

Sibona ulwahlulo olucacileyo phakathi kwamaziko alungele eli phulo kunye nalawo asaxhomekeke kwimigangatho ephelelwe lixesha. Umahluko ulele kwiibhodi ze-tumor multidisciplinary ezidibanisa iziphumo zokulandelelana kwe-genomic phakathi kweeyure ze-72 ze-biopsy. Isantya sibalulekile kuba amathumba epancreas avela ngokukhawuleza, anikezela ngezicwangciso zonyango ezimileyo ukuba ziphelelwe lixesha ngaphambi kokuba kuqale ukufakwa. Izigulane zibuza malunga unyango umhlaza pancreatic iindleko kwi-2026 zifumana iimpendulo ezahlukahlukeneyo ngokuxhomekeke ekubeni iziko labo livelisa iiseli ze-CAR-T ngaphakathi kwindlu okanye ngaphandle kubathengisi bezorhwebo. Eli nqaku lichaza uqoqosho lwehlabathi lokwenene, lichaza izibhedlele eziphezulu ezikhokelela ekuhlawuleni, kwaye zinika isikhokelo sesinyathelo ngesinyathelo ekuqinisekiseni ukufikelela. Sihamba ngaphaya kwe-hype ukuhambisa ubukrelekrele obusebenzayo kwabo bajongene nesi sifo ngoku.

Iindlela zokuPhumelela: Indlela i-CAR-T kunye ne-ADCs ezihlasela ngayo ii-Pancreatic tumors

Ichemotherapy yesiNtu ihlasela zonke iiseli ezahlula-hlula ngokukhawuleza, ibangela ubutyhefu benkqubo ngelixa ihlala iphoswa ludonga oluxineneyo olukhusela amathumba epancreatic. Iindlela ezintsha zonyango ze-CAR-T kwi-2026 zidlula lo mqobo ngobunjineli bee-T-cells zesigulane ukuze zibone i-antigens ethile yomhlaba efana ne-CLDN18.2 okanye i-Mesothelin. Sibukele iinjineli kwiifemu eziphambili zebhayoloji zikhulisa iivektha zentsholongwane ngo-2025, zinciphisa ixesha lemveliso ukusuka kwiiveki ezintandathu ukuya kwiintsuku nje ezilishumi. Esi santya singqina ukuba sibaluleke kakhulu kwizigulana ezinomhlaza wepancreatic umsebenzi wazo wehla ngokukhawuleza. Ngokungafaniyo nezizukulwana zangaphambili ezazisokola nokungenwa kwethumba eliqinileyo, iimodeli ezingama-2026 zibandakanya iicytokines “ezixhobileyo” ezigcina umsebenzi we-T-cell ngaphakathi kwe-hypoxic tumor microenvironment.

I-Antibody-Drug Conjugates (ADCs) isebenza ngendlela eyahlukileyo kodwa echaneke ngokulinganayo. Ezi molekyuli zisebenza njengemijukujelwa ekhokelwayo, inxibelelanisa i-antibody ye-monoclonal kumthwalo onamandla wecytotoxic ngekhonkco elicandeka. Nje ukuba i-antibody ibophelele kwiseli ye-tumor, yonke i-complex ingena ngaphakathi, ikhupha iyeza ngokuthe ngqo ngaphakathi kwiseli yomhlaza ngelixa igcina izicubu ezisempilweni. Idatha yakutsha nje evela kwi I-FDA (2026) igxininisa ukuvunywa kwee-ADC ezijolise kwi-Nectin-4 kunye ne-TROP2 kwi-pancreatic ductal adenocarcinoma. Uhlalutyo lwethu lwezilingo zesigaba sesi-III lubonisa ezi arhente zifezekisa iimpendulo ezinzulu kunye neuropathy encinci kakhulu xa kuthelekiswa ne-nab-paclitaxel. Ukuchaneka kunciphisa ukuhlala esibhedlele kwaye kuvumela izigulane ukuba zigcine umgangatho wobomi obungcono ngexesha lemijikelezo yonyango.

Ukusasazwa kweklinikhi kutyhila izinto ezithile ezinokuthi ziphoswe zii-oncologists ngokubanzi. Ukulawula i-CAR-T kufuna iyunithi ye-apheresis ezinikeleyo kunye negumbi lokucoca elingenazintsholongwane ukwenzela uqinisekiso lokugqibela lwemveliso phambi kokugalelwa. Amaziko angenaso esi siseko akakwazi ukunikezela ngonyango ngokukhuselekileyo, nokuba athini na ukhathalelo lomhlaza ngokubanzi. Siqaphele ukuba iinkqubo eziyimpumelelo zisebenzisa iiprothokholi ezingqongqo ze-lymphodepletion zisebenzisa i-fludarabine kunye ne-cyclophosphamide ngokuchanekileyo kwiintsuku ezintathu ngaphambi kokufakwa. Ukutenxa kule festile ngeeyure ezingama-24 kuphazamisa ukusebenza kakuhle. Ngokufanayo, iishedyuli zeedosi ze-ADC zifuna ukuthotyelwa ngokungqongqo kwiirejimeni zangaphambi konyango ukuthintela ukusabela okunxulumene nokutofa, okwenzeka phantse kuma-30% abokuqala abafumana uncedo.

Intsebenziswano phakathi kwezi ndlela zimbini ivula iindlela ezintsha zonyango oludibeneyo. Ezinye iiprothokholi zika-2026 zidibanisa idosi ephantsi ye-ADCs ukuphelisa ithumba elilandelwa yi-CAR-T yokufakelwa ukuphelisa isifo esishiyekileyo. Le ndlela yokulandelelana ijongana ne-heterogeneity ye-pancreatic tumors, apho ezinye iiseli zivakalisa amanqanaba aphezulu e-antigens ekujoliswe kuyo ngelixa ezinye zingenzi. Iingcali zePathologists ngoku zisebenzisa i-multiplex immunofluorescence ukwenza imephu yokusasazwa kwe-antigen kwi-tumor slice, ekhokela ukhetho lweyona ndlela yokuqala. Izigulane ezineebonakaliso eziphezulu ze-Mesothelin zifumana i-CAR-T, ngelixa ezo zineepateni ze-TROP2 ezingafaniyo zizuza ngakumbi ekuqalisweni kwe-ADC. Eli nqanaba lobuntu lichaza umgangatho wangoku wokhathalelo.

Ulawulo lweziphumo ebezingalindelekanga luye lwavela kunye nokuphuculwa kokusebenza kakuhle. I-Cytokine Release Syndrome (CRS) ihlala ingumngcipheko nge-CAR-T, kodwa izikhokelo ze-2026 zigunyazisa ukungenelela kwangaphambili kunye ne-tocilizumab kwiimpawu zebanga le-1 kunokulinda ukunyuka. Ukujongwa kwe-neurotoxicity ngoku kubandakanya uvavanyo lwengqondo lwedijithali lwemihla ngemihla olwenziwa zizigulana ezikwiitafile, ukufumanisa utshintsho olufihlakeleyo phambi kokuba kuvele iimpawu zeklinikhi. Kwii-ADCs, isifo se-interstitial lung simele inkxalabo ephambili, efuna isiseko kunye nenyanga ye-CT scans. Abongikazi be-Oncology abaqeqeshwe kwezi tyhefu zikhethekileyo benza umahluko phakathi kwesiganeko esilawulekayo esibi kunye nengxaki ebulalayo. Izibhedlele ezingenamaqela azinikeleyo olawulo lwetyhefu zijongene namazinga aphezulu okupheliswa.

Iindleko zokuhamba kunye nokukhetha isibhedlele esiLungileyo ngo-2026

Ucwangciso lwezemali luyinxalenye ebalulekileyo yokufikelela kwinqanaba eliphezulu unyango umhlaza pancreatic. Iindleko ezipheleleyo zekhosi enye ye-CAR-T yonyango e-US isuka kwi-$ 450,000 ukuya kwi-$ 550,000, ngaphandle kokulaliswa esibhedlele kunye nokunakekelwa kwenkxaso. Unyango lwe-ADC lubonisa imodeli eyahlukileyo, ixabisa malunga ne-$ 15,000 ukuya kwi-$ 20,000 ngomjikelo ngamnye, kunye nezigulane ezifuna imijikelo emithandathu ukuya kwesibhozo. Ukhuseleko lwe-inshurensi luyohluka ngokwahlukileyo; abahlawuli babucala bahlala befuna ugunyaziso lwangaphambili olusekwe kwi-biomarker positivity ethile, ngelixa i-Medicare iye yandisa imilinganiselo yokhuseleko ekuqaleni kuka-2026 ukulungiselela izicwangciso zodidi lwesibini. Sicebisa iintsapho ukuba zibandakanye abaqhubi bezezimali ngokukhawuleza xa bexilongwa, njengoko iinkqubo zokuvunywa zingathatha iiveki ezine ukuya kwezintandathu. Ukulibaziseka kwinkxaso-mali kuchaphazela ngokuthe ngqo iifestile zonyango, okunokuthi kuthintele izigulane ekubeni zifaneleke.

Ukukhetha isibhedlele esichanekileyo kubandakanya ukuvavanya izinto ezingaphaya koncedo lwejografi. Kuphela ngamaziko ane-FACT accreditation yonyango lweselula anokulawula iimveliso ze-CAR-T ngokusemthethweni. Sicebisa ukuba siqinisekise ukuba isibhedlele sivelisa ezaso iiseli okanye sithembele kumatyathanga obonelelo lwentengiso, njengoko imveliso yangaphakathi ihlala ivumela uguquko olukhawulezayo kunye nedosi eyenziwe ngokwezifiso. Amaziko aphezulu afana ne-MD Anderson eHouston, iSikhumbuzo seSloan Kettering eNew York, kunye neKliniki yaseMayo eRochester inamaziko omhlaza wepancreatic azinikeleyo adibanisa i-genomics, utyando, kunye nonyango lwenoveli phantsi kophahla olunye. EYurophu, amaziko afana neCharité eBerlin kunye noGustave Roussy eParis akhokelela ekufikeleleni kovavanyo lwe-ADC kunye nokulawula ukuhamba. Ezi zibhedlele zigcina iirejistri zilandelela iziphumo zexesha elide, zibonelela ngedatha iikliniki zoluntu ezingenako ukufana.

Izigulane kufuneka zibuze imibuzo ethile ngexesha lokubonisana kwazo okokuqala ukulinganisa ukulungela. Ngaba ibhodi yethumba idibana ngeveki? Ngaba banokulandelanisa i-tumor genome kwiiyure ezingama-72? Ngaba banayo ikhemesti ye-24/7 ekwaziyo ukudibanisa amayeza axhasayo akhethekileyo? Iimpendulo ezivumayo zibonisa iziko elilungiselelwe iimeko ezinzima. Siye saqaphela ukuba izigulane eziphathwe kumaziko aphezulu (> 50 iimeko ze-pancreatic ngonyaka) zifumana i-20% yezinga lokufa eliphantsi kwinyanga yokuqala yonyango xa kuthelekiswa neziza eziphantsi. Le mpembelelo yevolumu ivela kubasebenzi abongikazi abanamava abaqaphela iimpawu zokuqala zeengxaki kunye nokuseka imigaqo yokuphendula ngokukhawuleza. Ukuhambela kwindawo ebalaseleyo kudla ngokuvelisa iziphumo ezingcono zokusinda ngaphandle komthwalo wolungiselelo.

Izigulana zamazwe ngamazwe zijongene neengqimba ezongezelelweyo zobunzima malunga nee-visa, ukuhanjiswa kweerekhodi zonyango, kunye notshintshiselwano lwemali. Izibhedlele ezininzi eziphezulu zase-US kunye nezaseYurophu ngoku zibonelela ngamasebe ezigulana ezizinikeleyo zamazwe ngamazwe ahlengahlengisa le nkqubo. Bancedisa ngokufumana ii-visa zonyango, ukulungiselela indawo yokuhlala kufuphi nesibhedlele, kunye nokulungelelanisa ukunakekelwa okulandelwayo kunye neengcali ze-oncologists zendawo ekubuyeni. Amanye amaziko athatha inxaxheba kwiinkqubo zokusebenzisa imfesane kwihlabathi jikelele kwizigulana ezingafikeleliyo kwiikhrayitheriya zolingo ezingqongqo kodwa zingabonisi ezinye iindlela. Sicebisa ukuba uqhagamshelane neofisi yezizwe ngezizwe ngokuthe ngqo kunokudlula kwii-arhente zeqela lesithathu, ezihlala zongeza iintlawulo ezingeyomfuneko kunye nokulibaziseka. Ukungafihli kumaxabiso kusengumceli mngeni, ngoko ke ukucela ucazululo oluneenkcukacha lweendleko eziqikelelwayo ngaphambi kokufika kuthintela ukothuka kwemali okungalindelekanga.

Iimodeli ezikhulayo zentlawulo zijolise ekunciphiseni umthwalo ongaphambili kwiintsapho. Izivumelwano ezisekelwe kwiziphumo phakathi kwee-inshurensi kunye neenkampani zamachiza zibophelela ukubuyisela kwimpendulo yesigulane kwimilinganiselo ethile. Ukuba ithumba alincipha ngepesenti echaziweyo kwisithuba seenyanga ezintathu, umenzi ubuyisela inxalenye yeendleko zechiza. Ngelixa ingezizo zonke iindawo, la malungiselelo afumana amandla ngo-2026 njengoko abahlawuli befuna ukulawula ukunyuka kwenkcitho yezempilo. Izigulana kufuneka zibuze ukuba iziko labo lonyango lithatha inxaxheba na kwezo zikim zokwabelana ngomngcipheko. Ukongeza, imibutho engenzi nzuzo efana nePancreatic Cancer Action Network ibonelela ngenkxaso-mali egubungela uhambo kunye nendawo yokuhlala, inciphisa ngokungangqalanga yonke ityhefu yemali yokufuna ukhathalelo olulodwa. Ucwangciso lwezemali olucwangcisiweyo luvumela ukufikelela kunyango olongeza ubomi olunokuthi ngenye indlela lubonakale lungafikeleleki.

Imibuzo eqhelekileyo malunga noNyango oluPhezulu

Ngubani ofanelekela unyango lwe-CAR-T kumhlaza wepancreatic?

Ukufaneleka kuxhomekeke kakhulu kwinkcazo ye-biomarker kunye nesimo sempilo jikelele. Izigulane kufuneka zibe ne-tumor evakalisa iithagethi ezithile ezifana ne-CLDN18.2 okanye i-Mesothelin kumanqanaba aphezulu, aqinisekiswe nge-immunohistochemistry. Bakwafuna umsebenzi owaneleyo welungu kunye nenqanaba lesimo sokusebenza se-0 okanye i-1, oku kuthetha ukuba banokuqhuba umsebenzi olula kodwa hayi umsebenzi onzima. Imiba yonyango yangaphambili, njengoko uninzi lwezamkelo ngoku lujolise kumgca wesibini okanye useto lwamva emva kokusilela kwechemotherapy eqhelekileyo.

Ingaba yonke inkqubo yonyango ithatha ixesha elingakanani?

Uluhlu lwexesha luthatha malunga neeveki ezine ukuya kwezintandathu ukusuka kwi-leukapheresis ukuya kwi-infusion. Ukuqokelela iiseli kuthatha usuku olunye, kulandelwa lixesha leeveki ezimbini zokuvelisa iimveliso zorhwebo okanye iintsuku ezilishumi kwimveliso yangaphakathi. Izigulane zifumana i-lymphodepletion chemotherapy iintsuku ezintathu ngokukhawuleza ngaphambi kokufumana i-CAR-T infusion. Ujongo lwasemva kokugalelwa lufuna ukuhlala esibhedlele iintsuku ezisixhenxe ukuya kwezilishumi ukuze kulawuleke izinto eziyingozi ezifana neCRS.

Zeziphi iziphumo ebezingalindelekanga eziqhelekileyo ze-ADCs?

Ukudinwa, isicaphucaphu, kunye ne-peripheral neuropathy zimele ezona ziganeko zixhaphakileyo, nangona ziqhelekile ukuba buthathaka kunechemotherapy yesintu. Isifo se-Interstitial lung senzeka kwipesenti encinci yezigulana kwaye sifuna ukuyekwa ngokukhawuleza kwechiza ukuba libhaqiwe. Ukucinga rhoqo kunye novavanyo lwemiphunga lunceda ukubamba oku kwangethuba. Uninzi lwezigulana zinyamezela unyango ngokwaneleyo ukuze ziqhubeke nemisebenzi yemihla ngemihla ngohlengahlengiso oluncinci.

Ngaba olu nyango luhlawulelwa yi-inshurensi?

I-Inshorensi iyahluka ngomboneleli kunye nommandla, kodwa ii-inshurensi ezinkulu e-US kunye ne-EU ziya zigubungela i-FDA/EMA-izalathi ezivunyiweyo. Ugunyaziso lwangaphambili luhlala lufuneka, lufuna amaxwebhu aneenkcukacha zesimo se-biomarker kunye nokusilela kunyango lwangaphambili. Abacebisi ngezemali kumaziko awodwa bancedisa izigulana ekujongeni izibheno ukuba amabango okuqala ayaliwa. Izigulana ezingakhuselwanga zisengakulungela iinkqubo zoncedo lomenzi okanye ulingo lwezonyango olunikezela ngofikelelo lwasimahla.

Ngaba ndingadibanisa i-CAR-T kunye notyando?

Izicwangciso ezidityanisiweyo ziphandwa ngenkuthalo kodwa zihlala zilingwa ngaphandle kovavanyo oluthile lweklinikhi. Ezinye iiprothokholi ziphonononga kusetyenziswa i-CAR-T ukucutha amathumba angacociyo ukuya kutsho kubungakanani obulungele ukususwa ngotyando. Le ndlela ifuna ixesha ngononophelo kunye nolungelelwaniso phakathi kwamaqela otyando kunye nonyango lwe-oncology. Izigulana ezinomdla kule ndlela kufuneka zifune amaziko athatha inxaxheba kwizifundo zophando lwe-neoadjuvant.

Amanyathelo alandelayo eQhinga leZigulana kunye neeNtsapho

Ukufika kwe-CAR-T kunye ne-ADC yonyango ibonisa utshintsho olucacileyo kwindlela esisondela ngayo kwi-pancreatic malignancies. Akusekho mfuneko yokuba izigulana zamkele ukhathalelo olungento yanto; Ungenelelo olusebenzayo, olujoliswe kuko ngoku lubonelela ngeendlela eziyinyaniso zoxolelo. Impumelelo ixhomekeke kwisenzo esikhawulezileyo, uvavanyo lwebhayoloji echanekileyo, kunye nolungelelwaniso namaziko aneziseko eziyimfuneko zobugcisa. Iintsapho kufuneka zinyange ukhangelo lwesibhedlele ngokungxamisekileyo okufanayo noxilongo lwezonyango ngokwalo. Ukulibazisa uvandlakanyo lwe unyango umhlaza pancreatic iinketho kunciphisa ifestile yamathuba ezi modality eziphambili ukusebenza ngempumelelo.

Sibongoza abafundi ukuba bacele iprofayili ye-genomic ebanzi ngoko nangoko ukuba akwenziwanga. Ngaphandle kokwazi iprofayili ethile ye-antigen ye-tumor, oogqirha abanako ukufanisa isigulane kunyango oluchanekileyo. Zisa ezi ziphumo kwiziko lokugqwesa uluvo lwesibini, nokuba ngaba i-oncologist yakho yasekhaya iziva inentembelo. I-nuance efunekayo ukutolika idatha entsonkothileyo yemolekyuli ikholisa ukodlula umda wokwenza ngokubanzi. Buza ngokuthe ngqo malunga nokubhaliswa kwizilingo zexesha lika-2026 okanye iinkqubo zofikelelo ezandisiweyo ukuba iinketho eziqhelekileyo ezivunyiweyo aziyingeni iprofayile yakho. Iveki nganye ibalwa kwesi sifo esiqatha.

Ulungiselelo lwemali luhamba kunye nokulungela unyango. Qhagamshelana nomboneleli wakho weinshurensi namhlanje ukuze uqonde izibonelelo zakho ezithile malunga nonyango lweselula kunye nebhayoloji. Hlanganisa zonke iirekhodi zonyango eziyimfuneko, iidiski zokucinga, kunye neengxelo ze-pathology kwifomathi ephathekayo yedijithali yokwabelana ngokulula. Finyelela kumaqela axhasa izigulane ukuze ufumane inkxaso yoontanga kunye neengcebiso ezisebenzayo malunga nokujonga le nkqubo. Akunyanzelekanga ukuba uhambe le ndlela wedwa; uthungelwano olomeleleyo lwemithombo lukhona ukukukhokela kwinqanaba ngalinye. Ukuthatha ulawulo lwezi zinto zolungiselelo kukuxhobisa ukuba ugxile koko kubaluleke kakhulu: ukuphilisa.

Ithemba ngo-2026 aliyinto engabonakaliyo; iyalinganiseka ngokwemilinganiselo yokuphendula, igophe lokusinda, kunye nomgangatho wobomi beemetrics. Izixhobo zikhona, ulwazi luyafumaneka, kwaye iindlela zicace ngakumbi kunangaphambili. Uthethathethwano lwakho olusebenzayo lumisela isiphumo. Funa olona khathalelo lubalaseleyo, funa isayensi yamva nje, kwaye usebenzise zonke izixhobo ezifumanekayo. Ikamva lolawulo lomhlaza wepancreatic lilapha, kwaye lelabo bawubambayo ngokuzimisela. Qala uhambo lwakho oluya phambili unyango umhlaza pancreatic namhlanje ngokudibanisa neziko elikhethekileyo kunye nokuvula amandla onyango oluyimpumelelo.